| 000 | 01575 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516144937.0 | ||
| 264 | 0 | _c20140318 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1434-9949 | ||
| 024 | 7 |
_a10.1007/s10067-013-2261-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrachana, Maria | |
| 245 | 0 | 0 |
_aAchievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cAug 2013 |
||
| 300 |
_a1191-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aJoints _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUveitis _xdiagnosis |
| 700 | 1 | _aPratsidou-Gertsi, Polyxeni | |
| 700 | 1 | _aBadouraki, Maria | |
| 700 | 1 | _aHaidich, Anna Bettina | |
| 700 | 1 | _aPardalos, Grigoris | |
| 773 | 0 |
_tClinical rheumatology _gvol. 32 _gno. 8 _gp. 1191-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-013-2261-z _zAvailable from publisher's website |
| 999 |
_c22687165 _d22687165 |
||